GUERRA LUCA

Franco, G., Promi, S., Galbardi, I., Paciocco, G., Allegranza, P., Cangiotti, C., et al. (2026). A hypermetabolic pulmonary lesion in a patient with breast cancer. BREATHE, 22(2) [10.1183/20734735.0042-2026]. Dettaglio

Bauckneht, M., Evangelista, L., Sofia, L., Maccauro, M., Filice, A., De Rimini, M., et al. (2026). Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: PSA persistence, biochemical recurrence, hormone-sensitive and castration-resistant metastatic settings. CLINICAL AND TRANSLATIONAL IMAGING [10.1007/s40336-026-00766-8]. Dettaglio

Monaco, L., Crivellaro, C., De Bernardi, E., Bono, F., Casati, G., Seminati, D., et al. (2025). Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 19 [10.1177/17534666251384433]. Dettaglio

Durmo, R., Chauvie, S., Minoia, C., Bergesio, F., Fallanca, F., Peano, S., et al. (2025). Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial. AMERICAN JOURNAL OF HEMATOLOGY, 100(7), 1196-1204 [10.1002/ajh.27711]. Dettaglio

Durmo, R., Chauvie, S., Fallanca, F., Bergesio, F., Pinto, A., Del Giudice, I., et al. (2025). Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi. BLOOD ADVANCES, 9(12), 2927-2934 [10.1182/bloodadvances.2024014790]. Dettaglio